Mirum Pharmaceuticals, Inc.
MIRM
Classement en actions
#3241
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Prix de l'action
$83.62
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$5.43B
Changement (1 jour)
-1.71%
Changement (1 an)
20.14%
Pays
US
Échange Mirum Pharmaceuticals, Inc. (MIRM)
Catégorie
Healthcare
Historique du prix de l'action pour Mirum Pharmaceuticals, Inc. (MIRM)
Prix de clôture le plus élevé : $82.31 le 2026-10-01
Prix de clôture le plus bas : $13.66 le 2019-07-01
Prix de clôture le plus bas : $13.66 le 2019-07-01
Historique du prix de l'action de Mirum Pharmaceuticals, Inc. de 2019 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 28.91% |
| 2025 | 68.24% |
| 2024 | 35.06% |
| 2023 | 73.09% |
| 2022 | 24.19% |
| 2021 | -29.47% |
| 2020 | 29.71% |
| 2019 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $765.49 | 8.80% |
CH
|
